semaglutide short term use Short-Term GLP-1 Weight Loss Results Who Qualifies for Ozempic for

Amgen's 2026 real-world evidence presentations noted that GLP-1 benefits are closely tied to sustained treatment use, while many patients discontinue within the first year in routine practice

Mild dehydration and electrolyte imbalance are common early contributors to fatigue and are often overlooked

& Suri, P

Athauda D, Maclagan K, Skene SS et al (2017) Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

BMI and Body Weight: GLP-1 RAs were associated with notable reductions in both body mass index (BMI) and body weight across a wide range of populations